Long-term cyclosporin A in systemic sclerosis [11]

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 2, 2004, Pages 235-236

  Roch, B ^a   Wollina, U ^b   Schroeder, H E ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCIUM ANTAGONIST; CORTICOSTEROID; CYCLOSPORIN A; PROTON PUMP INHIBITOR; STEROID;

BARRETT ESOPHAGUS; CASE REPORT; CONNECTIVE TISSUE DISEASE; DISEASE COURSE; DOSE RESPONSE; DRUG TOLERABILITY; DUODENOSCOPY; DYSPNEA; ESOPHAGUS MANOMETRY; EXERCISE; FACE EDEMA; FATIGUE; FEMALE; FINGER; HUMAN; HYPERTENSION; HYPERTRICHOSIS; LETTER; LONG TERM CARE; LUNG FUNCTION TEST; MUSCLE WEAKNESS; NEPHROTOXICITY; PAIN; PATIENT MONITORING; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RAYNAUD PHENOMENON; REFLUX ESOPHAGITIS; STOMATITIS; SYSTEMIC SCLEROSIS;

ADULT; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SCLERODERMA, SYSTEMIC;

EID: 1642370073     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00717.x     Document Type: Letter

References (5)

1. Medsger TA. Treatment of systemic sclerosis. Ann Rheum Dis 1991; 50: 877-886.
2. Clements PJ, Lachenbruch PA, Sterz M, Danovitch G, Hawkins R, Ippoliti A, Paulus HE. Cyclosporine in systemic sclerosis. Results of a forty-eight-week open safety study in ten patients. Arthritis Rheum 1994; 37: 301-302.
3. Filaci G, Cutolo M, Scudeletti M et al. Cyclosporin A and iloprost treatment of systemic sclerosis: Clinical results and interleukin-6 serum changes after 12 months of therapy. Rheumatology 1999; 38: 992-996.
4. Morton SJ, Powell RJ. Cyclosporin and tacrolimus: Their use in a routine clinical setting for scleroderma. Rheumatology (Oxford) 2000; 39: 865-869.
5. Wigley FM. Treatment of systemic sclerosis. Curr Opin Rheumatol 1992; 4: 878-886.